Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008
- Creator
-
Schnepf, N.
- Contributor
-
Lafuente-Lafuente, C.
Jarrin, I.
Simoneau, G.
Magnier, JD
Trylesinski, A.
Sellier, P.
Mazeron, MC
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P279
- URN
-
urn:nbn:de:1111-2016052056099
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schnepf, N.
- Lafuente-Lafuente, C.
- Jarrin, I.
- Simoneau, G.
- Magnier, JD
- Trylesinski, A.
- Sellier, P.
- Mazeron, MC
- SpringerLink (Online service)
Other Objects (12)
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infection
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México
Suppression of HBV by Tenofovir in HBV/HIV coinfected patients : a systematic review and meta-analysis [[Elektronische Ressource]]
Fernmeldezentrale - HBV
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infection
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México
Suppression of HBV by Tenofovir in HBV/HIV coinfected patients : a systematic review and meta-analysis [[Elektronische Ressource]]
Fernmeldezentrale - HBV
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Transmission of Hepatitis B virus (HBV) minor variants in children born to HBV/HIV co-infected mothers
Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infection
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México
Suppression of HBV by Tenofovir in HBV/HIV coinfected patients : a systematic review and meta-analysis [[Elektronische Ressource]]